Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord Blood Therapy for Cerebral Palsy
NCT01528436Phase 2Completed
- Start
- Feb 2012
- Primary completion
- Jul 2012
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of umbilical cord blood in cerebral palsy (CP). Primary endpoints: Changes in Motor Performance at 12 weeks and Changes in Standardized Gross Motor Function at 12 weeks. Started Feb 2012; status: completed.
02
Drugs
umbilical cord blood
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT01528436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01528436.